Literature DB >> 7679533

Tumor markers in testis cancer.

E A Klein1.   

Abstract

Human chorionic gonadotropin and alpha-fetoprotein are well established as serum markers for germ-cell tumors of the testis. Other protein markers of this disease are lactic acid dehydrogenase and placental alkaline phosphatase. There also are cytogenetic or chromosomal markers, particularly i(12p), and molecular markers in the form of oncogenes and tumor suppressor genes. Markers are valuable in diagnosis, staging, predicting tumor behavior, and monitoring therapy and disease recurrence.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7679533

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  11 in total

1.  Failure of normalisation of alpha fetoprotein concentration after successful treatment of teratoma.

Authors:  H S Pandha; H S Wasan; K Harrington; J Waxman
Journal:  BMJ       Date:  1995-08-12

Review 2.  Oncogenes in tumor metabolism, tumorigenesis, and apoptosis.

Authors:  C V Dang; B C Lewis; C Dolde; G Dang; H Shim
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

3.  Results of salvage retroperitoneal lymphadenectomy (RLA) in the treatment of patients with nonseminomatous germ cell tumours remaining marker positive after inductive chemotherapy.

Authors:  L Kisbenedek; I Bodrogi; P Szeldeli; M Baki; P Tenke; J Horti
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

4.  Management of testicular cancer with combined-modality treatment.

Authors:  M Lekili; S Minareci; N Nergis; U Serim; A R Ayder
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

5.  A human monoclonal antibody specific to placental alkaline phosphatase, a marker of ovarian cancer.

Authors:  Niccolò Ravenni; Marcel Weber; Dario Neri
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

6.  Characteristics of thymoma successfully resected by videothoracoscopic surgery.

Authors:  Yu-Jen Cheng; Jui-Sheng Hsu; Eing-Long Kao
Journal:  Surg Today       Date:  2007-03-09       Impact factor: 2.549

7.  125I-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer.

Authors:  T B Christensen; F Engbaek; J Marqversen; S I Nielsen; C Kamby; H von der Maase
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

Review 8.  Tumour markers and kidney function: a systematic review.

Authors:  Giuseppe Coppolino; Davide Bolignano; Laura Rivoli; Giuseppe Mazza; Piera Presta; Giorgio Fuiano
Journal:  Biomed Res Int       Date:  2014-02-06       Impact factor: 3.411

Review 9.  Clinically Meaningful Use of Blood Tumor Markers in Oncology.

Authors:  Stefan Holdenrieder; Lance Pagliaro; David Morgenstern; Farshid Dayyani
Journal:  Biomed Res Int       Date:  2016-11-30       Impact factor: 3.411

10.  Current management of testicular cancer.

Authors:  Yu Seob Shin; Hyung Jin Kim
Journal:  Korean J Urol       Date:  2013-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.